These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


193 related items for PubMed ID: 32876732

  • 1. The effect of sublingual atropine sulfate on clozapine-induced hypersalivation: a multicentre, randomised placebo-controlled trial.
    Mubaslat O, Lambert T.
    Psychopharmacology (Berl); 2020 Oct; 237(10):2905-2915. PubMed ID: 32876732
    [Abstract] [Full Text] [Related]

  • 2. Glycopyrrolate in comparison to hyoscine hydrobromide and placebo in the treatment of hypersalivation induced by clozapine (GOTHIC1): study protocol for a randomised controlled feasibility study.
    Qurashi I, Chu S, Husain N, Drake RJ, Chaudhry I, Deakin JF.
    Trials; 2016 Nov 21; 17(1):553. PubMed ID: 27871302
    [Abstract] [Full Text] [Related]

  • 3. Sublingual atropine for the treatment of severe and hyoscine-resistant clozapine-induced sialorrhea.
    Mustafa FA, Khan A, Burke J, Cox M, Sherif S.
    Afr J Psychiatry (Johannesbg); 2013 Jul 21; 16(4):242. PubMed ID: 24051562
    [No Abstract] [Full Text] [Related]

  • 4. Therapeutic effect of pirenzepine for clozapine-induced hypersalivation: a randomized, double-blind, placebo-controlled, cross-over study.
    Bai YM, Lin CC, Chen JY, Liu WC.
    J Clin Psychopharmacol; 2001 Dec 21; 21(6):608-11. PubMed ID: 11763010
    [Abstract] [Full Text] [Related]

  • 5. Sublingual atropine in the treatment of clozapine-induced sialorrhea.
    Matos Santana TE, Capurso NA, Ranganathan M, Yoon G.
    Schizophr Res; 2017 Apr 21; 182():144-145. PubMed ID: 27816262
    [No Abstract] [Full Text] [Related]

  • 6. Double-Blind, Randomized, Placebo-Controlled Trial of Metoclopramide for Hypersalivation Associated With Clozapine.
    Kreinin A, Miodownik C, Mirkin V, Gaiduk Y, Yankovsky Y, Bersudsky Y, Lerner PP, Bergman J, Lerner V.
    J Clin Psychopharmacol; 2016 Jun 21; 36(3):200-5. PubMed ID: 27028980
    [Abstract] [Full Text] [Related]

  • 7. Sublingual Atropine Administration for Clozapine-Induced Sialorrhea in Bipolar Disorder: A Case Report Highlighting its Efficacy, Safety Concerns and Challenges.
    Afroz O, Garg S, Kumar A, Kathiresan P, Mishra D, Deep R.
    Psychopharmacol Bull; 2024 Aug 19; 54(4):124-130. PubMed ID: 39263201
    [Abstract] [Full Text] [Related]

  • 8. Hyoscine for clozapine-induced hypersalivation: a double-blind, randomized, placebo-controlled cross-over trial.
    Segev A, Evans A, Hodsoll J, Whiskey E, Sheriff RS, Shergill S, MacCabe JH.
    Int Clin Psychopharmacol; 2019 Mar 19; 34(2):101-107. PubMed ID: 30614850
    [Abstract] [Full Text] [Related]

  • 9. Trihexyphenidyl treatment of clozapine-induced hypersalivation.
    Spivak B, Adlersberg S, Rosen L, Gonen N, Mester R, Weizman A.
    Int Clin Psychopharmacol; 1997 Jul 19; 12(4):213-5. PubMed ID: 9347382
    [Abstract] [Full Text] [Related]

  • 10. Intraoral application of atropine sulfate ophthalmic solution for clozapine-induced sialorrhea.
    Sharma A, Ramaswamy S, Dahl E, Dewan V.
    Ann Pharmacother; 2004 Sep 19; 38(9):1538. PubMed ID: 15252196
    [No Abstract] [Full Text] [Related]

  • 11. Use of Sublingual Atropine Drops in Clozapine-Associated Sialorrhea in an Adolescent Patient: A Case Report.
    Akça D, Güneş A, Karaçetin G.
    J Clin Psychopharmacol; 2004 Sep 19; 42(6):606-607. PubMed ID: 36251377
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation and Comparison of the Effectiveness of Atropine Eye Drops, Ipratropium Bromide Nasal Spray, and Amitriptyline Tablet in the Management of Clozapine-Associated Sialorrhea in Patients With Refractory Schizophrenia: A Randomized Clinical Trial.
    Mohammad-Gholizad F, Karimzadeh I, Moghimi-Sarani E, Arshadi M, Mortazavi N.
    J Clin Psychopharmacol; 2004 Sep 19; 44(1):9-15. PubMed ID: 38100776
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness of the repeated administration of scopolamine ointment on clozapine-induced hypersalivation in patients with treatment-resistant schizophrenia: A preliminary study.
    Takeuchi I, Hanya M, Uno J, Fujita K, Kamei H.
    Asia Pac Psychiatry; 2017 Dec 19; 9(4):. PubMed ID: 29193710
    [Abstract] [Full Text] [Related]

  • 14. Association Between N-Desmethylclozapine and Clozapine-Induced Sialorrhea: Involvement of Increased Nocturnal Salivary Secretion via Muscarinic Receptors by N-Desmethylclozapine.
    Ishikawa S, Kobayashi M, Hashimoto N, Mikami H, Tanimura A, Narumi K, Furugen A, Kusumi I, Iseki K.
    J Pharmacol Exp Ther; 2020 Nov 19; 375(2):376-384. PubMed ID: 32862145
    [Abstract] [Full Text] [Related]

  • 15. [Treatment options for drug-induced sialorrhea: Prescribing guidelines].
    Cuvelier E, Gressier B, Fovet T, Simon N, Décaudin B, Amad A.
    Encephale; 2022 Dec 19; 48(6):700-711. PubMed ID: 35989107
    [Abstract] [Full Text] [Related]

  • 16. Sublingual atropine for sialorrhea secondary to parkinsonism: a pilot study.
    Hyson HC, Johnson AM, Jog MS.
    Mov Disord; 2002 Nov 19; 17(6):1318-20. PubMed ID: 12465075
    [Abstract] [Full Text] [Related]

  • 17. The Effect of Glycopyrrolate on Nocturnal Sialorrhea in Patients Using Clozapine: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial.
    Man WH, Colen-de Koning JC, Schulte PF, Cahn W, van Haelst IM, Doodeman HJ, Egberts TC, Heerdink ER, Wilting I.
    J Clin Psychopharmacol; 2017 Apr 19; 37(2):155-161. PubMed ID: 28129312
    [Abstract] [Full Text] [Related]

  • 18. Clozapine-induced hypersalivation.
    Davydov L, Botts SR.
    Ann Pharmacother; 2000 May 19; 34(5):662-5. PubMed ID: 10852096
    [Abstract] [Full Text] [Related]

  • 19. Treatment of drooling with sublingual atropine sulfate in children and adolescents with cerebral palsy.
    Dias BLS, Fernandes AR, Maia HS.
    Arq Neuropsiquiatr; 2017 May 19; 75(5):282-287. PubMed ID: 28591387
    [Abstract] [Full Text] [Related]

  • 20. Anticholinergic medication for non-clozapine neuroleptic-induced hypersalivation in people with schizophrenia.
    Essali A, Rihawi A, Altujjar M, Alhafez B, Tarboush A, Alhaj Hasan N.
    Cochrane Database Syst Rev; 2013 Dec 19; 2013(12):CD009546. PubMed ID: 24353163
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.